中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2014年
30期
26-26,27
,共2页
溃疡性结肠炎%美沙拉嗪%麦滋林
潰瘍性結腸炎%美沙拉嗪%麥滋林
궤양성결장염%미사랍진%맥자림
Ulcerative colitis%Mesalamine%Maizulene
目的:评价美沙拉嗪联合麦滋林治疗溃疡性结肠炎(UC)的疗效。方法将确诊的92例轻、中度UC患者分为两组,治疗组(n=46)口服美沙拉嗪+麦滋林;对照组(n=46)口服美沙拉嗪,治疗3个月后评价治疗效果。结果3个月后治疗组有效率93.4%,明显高于对照组的80.4%(P<0.01)。结论美沙拉嗪联合麦滋林治疗UC效果显著,值得临床推广。
目的:評價美沙拉嗪聯閤麥滋林治療潰瘍性結腸炎(UC)的療效。方法將確診的92例輕、中度UC患者分為兩組,治療組(n=46)口服美沙拉嗪+麥滋林;對照組(n=46)口服美沙拉嗪,治療3箇月後評價治療效果。結果3箇月後治療組有效率93.4%,明顯高于對照組的80.4%(P<0.01)。結論美沙拉嗪聯閤麥滋林治療UC效果顯著,值得臨床推廣。
목적:평개미사랍진연합맥자림치료궤양성결장염(UC)적료효。방법장학진적92례경、중도UC환자분위량조,치료조(n=46)구복미사랍진+맥자림;대조조(n=46)구복미사랍진,치료3개월후평개치료효과。결과3개월후치료조유효솔93.4%,명현고우대조조적80.4%(P<0.01)。결론미사랍진연합맥자림치료UC효과현저,치득림상추엄。
Objective?To evaluate Mesalazine combined with Maizulene treatment of ulcerative colitis clinical efifcacy. Methods?92?patients?diagnosed?with?ulcerative?were?randomly?divided?into?combined?group?and?control?group?with?46?cases,?combined?group?with?Mesalazine?and?Maizulene,?control?group?with Mesalazine, and the efifcacy were compared after treatment 3 moons. Results?After?treatment,?the?combined?group's?total?effective?rate?of?93.4%?over?the effective rate of 80.4%of control group(P<0.01).?Conclusion?Mesalazine combined with Maizulene for ulcerative colitis efifcacy is better, worthy of being?popularized.